Workflow
25 Worst Stocks to Own in January
PFEPfizer(PFE) Schaeffers Investment Research·2024-12-30 17:21

Policy Impact on Vaccine Stocks - The selection of Robert F Kennedy Jr to lead the Department of Health and Human Services is putting pressure on vaccine stocks, potentially signaling cautious investors to avoid Pfizer Inc (PFE) [1] - Pfizer stock has historically underperformed in January, with an average loss of 4 6% over the past 10 years and finishing the month in the red eight times [2] Pfizer Stock Performance - Pfizer stock is currently at 2639,withapotentialdropto26 39, with a potential drop to 25 if historical trends continue [2] - The stock is down 8 2% in 2024 but is on track for a small December gain, breaking a four-month losing streak [3] - The stock recently dipped to 2448onNov15,itslowestlevelsinceJanuary2013[3]OptionsandVolatility−Pfizer′sSchaeffer′sVolatilityIndex(SVI)isat2024 48 on Nov 15, its lowest level since January 2013 [3] Options and Volatility - Pfizer's Schaeffer's Volatility Index (SVI) is at 20%, ranking in the 11th percentile over the last 12 months, making options an attractive route [4] - The Schaeffer's Volatility Scorecard (SVS) for Pfizer is relatively low at 30 out of 100, indicating it is a prime candidate for short-term selling [4] - The Schaeffer's put/call open interest ratio (SOIR) of 0 55 is in the 1st percentile, showing a preference for calls among short-term traders [7] Historical January Performance - Pfizer is among the worst-performing S&P 500 stocks in January, with a median return of -2 75% and only 20% positive returns historically [5] - Other stocks with poor January performance include UPS (-4 81%), ABBV (-4 36%), and HUM (-2 71%) [5] Recent Trading Data - Pfizer's daily chart since January 2024 shows a trading range of 26 24 to 2657,withaclosingpriceof26 57, with a closing price of 26 34, down 1 05% [6]